GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Covalon Technologies Ltd (TSXV:COV) » Definitions » Cyclically Adjusted PB Ratio

Covalon Technologies (TSXV:COV) Cyclically Adjusted PB Ratio : 1.59 (As of May. 24, 2024)


View and export this data going back to 2004. Start your Free Trial

What is Covalon Technologies Cyclically Adjusted PB Ratio?

As of today (2024-05-24), Covalon Technologies's current share price is C$1.10. Covalon Technologies's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 was C$0.69. Covalon Technologies's Cyclically Adjusted PB Ratio for today is 1.59.

The historical rank and industry rank for Covalon Technologies's Cyclically Adjusted PB Ratio or its related term are showing as below:

TSXV:COV' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.52   Med: 2.67   Max: 11.02
Current: 1.57

During the past years, Covalon Technologies's highest Cyclically Adjusted PB Ratio was 11.02. The lowest was 0.52. And the median was 2.67.

TSXV:COV's Cyclically Adjusted PB Ratio is ranked better than
52.61% of 652 companies
in the Biotechnology industry
Industry Median: 1.74 vs TSXV:COV: 1.57

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Covalon Technologies's adjusted book value per share data for the three months ended in Dec. 2023 was C$0.716. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is C$0.69 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Covalon Technologies Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Covalon Technologies's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Covalon Technologies Cyclically Adjusted PB Ratio Chart

Covalon Technologies Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.49 2.12 4.63 3.91 2.17

Covalon Technologies Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.69 3.47 2.61 2.17 1.54

Competitive Comparison of Covalon Technologies's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Covalon Technologies's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Covalon Technologies's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Covalon Technologies's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Covalon Technologies's Cyclically Adjusted PB Ratio falls into.



Covalon Technologies Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Covalon Technologies's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=1.10/0.69
=1.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Covalon Technologies's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Covalon Technologies's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book=Book Value per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.716/125.0724*125.0724
=0.716

Current CPI (Dec. 2023) = 125.0724.

Covalon Technologies Quarterly Data

Book Value per Share CPI Adj_Book
201403 0.707 98.604 0.897
201406 0.684 99.473 0.860
201409 0.594 99.394 0.747
201412 0.573 98.367 0.729
201503 0.606 99.789 0.760
201506 0.596 100.500 0.742
201509 0.514 100.421 0.640
201512 0.548 99.947 0.686
201603 0.413 101.054 0.511
201606 0.344 102.002 0.422
201609 0.197 101.765 0.242
201612 0.234 101.449 0.288
201703 0.262 102.634 0.319
201706 0.409 103.029 0.497
201709 0.421 103.345 0.510
201712 0.467 103.345 0.565
201803 0.479 105.004 0.571
201806 0.610 105.557 0.723
201809 0.596 105.636 0.706
201812 0.623 105.399 0.739
201903 0.600 106.979 0.701
201906 0.457 107.690 0.531
201909 0.578 107.611 0.672
201912 0.532 107.769 0.617
202003 0.458 107.927 0.531
202006 0.446 108.401 0.515
202009 0.353 108.164 0.408
202012 0.310 108.559 0.357
202103 0.321 110.298 0.364
202106 0.353 111.720 0.395
202109 1.290 112.905 1.429
202112 1.215 113.774 1.336
202203 1.126 117.646 1.197
202206 1.076 120.806 1.114
202209 0.958 120.648 0.993
202212 0.934 120.964 0.966
202303 0.890 122.702 0.907
202306 0.856 124.203 0.862
202309 0.762 125.230 0.761
202312 0.716 125.072 0.716

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Covalon Technologies  (TSXV:COV) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Covalon Technologies Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Covalon Technologies's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Covalon Technologies (TSXV:COV) Business Description

Traded in Other Exchanges
Address
1660 Tech Avenue, Unit 5, Mississauga, ON, CAN, L4W 5S7
Covalon Technologies Ltd is principally engaged in the business of developing, licensing, and selling medical technologies. The company develops advanced wound care line which is designed for the treatment of a wide range of wounds; and infection prevention products such as MediClear PreOp which is a breathable, transparent, self-adhesive silicone barrier film that conforms to the contours of the body. It also develops perioperative care products. The company generates its revenue through development contracts, licensing agreements, and distribution contracts, and sales.
Executives
Valerio Ditizio Director or Senior Officer of 10% Security Holder, Senior Officer

Covalon Technologies (TSXV:COV) Headlines

No Headlines